Synthesis and Biological Screening of Novel Aminoalkyl Substituted Azaphenothiazine
Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM University, Kattankulathur - 603 203.
*Corresponding Author E-mail: valentina_7_srm@yahoo.com
ABSTRACT
Some novel series of alkyl substituted azaphenothiazine were synthesized by condensation of 2-chloro-1-(10H-azaphenothiazin-10yl) ethanone with various amines. The synthesized compounds were confirmed by IR, 1HNMR and Mass spectroscopy.. The bioavailabilities of the compounds were determined by Lipinski rule of 5 using customized software. All the compounds were screened for antimicrobial and sedative activity.
KEYWORDS: Azaphenothiazine, Bioavailability, Antimicrobial activity, Sedative activity.
INTRODUCTION:
Several antimicrobial drugs have been synthesized to prevent infections of several pathogenic microorganisms. Most of the researches have been carried out to develop therapeutically active phenothiazine derivatives. Phenothiazine nucleus containing drugs have been reported to possess anti-microbial and CNS effects.1 Replacement of one aromatic nucleus of phenothiazine by pyridine ring has been reported to possess more prominent biological activity2. Nitrogen containing heterocyclic compound like aza-phenothiazine have received considerable attention in recent years due to their biological activities like antihypertensive3 anti-histaminic4, anti-microbial5, sedative6 and anti-allergic6 activities. Since azaphenothiazin is bioisosteric isomer of phenothiazine, it is expected to have biological activities similar to phenothiazine. The present work reports the synthesis of alkyl substituted azaphenothiazine by condensation of 2-chloro-1-(10H-azaphenothiazin-10yl) ethanone with various amines (3a-j). The structures of the synthesized compounds were confirmed by their IR, 1HNMR and Mass spectral datas.The synthesized compounds were screened for anti-microbial and sedative activities.
EXPERIMENTAL:
Melting points were determined in open capillary tube and are uncorrected. IR spectra were recorded in Perkin- Elmer FTIR spectrophotometer using KBr disc. 1HNMR spectra were recorded on Varian 300 MHZ spectrometer with TMS as internal standard Mass spectra were recorded on LCMS-2010 using CDCl3 as solvent. The completion of reaction was tested by TLC using precoated TLC plate with varying composition of mobile phase. [chloroform: methanol: acetic acid]
General procedure for the preparation of azaphenothiazine derivatives 3a-j:
Azaphenothiazine was synthesized by the condensation of 2-amino thiophenol and 2-chloropyridine in presence of iodine as reported in the litrature5
Synthesis of 2-Chloro-1-(10H-azaphenothiazine-10-yl-) ethanone (2):
To a solution of chloroacetylchloride (0.2mol) in ethanol azaphenothiazine (0.2mol) was added drop wise and the solution was refluxed for one hour. The content was poured into cold water and the solid obtained was filtred, dried and recrystallized from ethanol to give a compound 2
Synthesis of 2-(amino substituted)-1-(10H- azaphenothiazine-10-yl-) ethanone (3a-j):
To the compound 2 (0.01mole), various amines (0.01mole) were added and dissolved in acetone .It was refluxed for 2 hours. Then, poured over crushed ice, solid thus obtained was recrystallized by methanol.
The physical characterization data of the synthesized compounds is given in Table 1. The spectral analysis has been reported in Table 2
BIOAVAILABILITY:
The bioavailability of the synthesized compounds was determined by Lipinski rule 7of 5 using customized software and data is described in Table 1.
ANTIMICROBIAL ACTIVITY:
All the compounds (3a-j) were screened for invitro antibacterial activity against Bacillus spharicus, Enterococcus feacalis, Vibrio cholerae and Salmonella typhi by disc diffusion technique8 at a concentration of 500µg/ml by measuring the zone of inhibition in mm and reported in Table 3. Amoxicillin was used as standard drug. Nutrient agar and DMF were used as culture medium and solvent control respectively.
Table 1. Physical characterization and bioavailability of compounds 3a-j
Physical Characterization |
Lipinski Rule of 5 |
|||||||
|
Compound |
R |
M.P (oC) |
Yield (%) |
Log P |
M.W |
No of H bond |
No of violation |
|
|
Acceptor |
Donor |
|||||||
|
3Ia |
Morpholinyl |
81 |
53 |
2.37 |
327.409 |
5 |
0 |
0 |
|
3b |
N-methyl Piperazinyl |
79 |
86 |
2.42 |
340.452 |
4 |
0 |
0 |
|
3c |
Pyrrolyl |
89 |
45 |
3.66 |
307.378 |
4 |
0 |
0 |
|
3d |
Pyrrolidinyl |
75 |
60 |
2.93 |
311.411 |
4 |
0 |
0 |
|
3e |
Piperazinyl |
80 |
75 |
1.82 |
326.425 |
5 |
1 |
0 |
|
3f |
Diethyl aminyl |
87 |
46 |
3.28 |
313.462 |
4 |
0 |
0 |
|
3g |
Imidazolyl |
85 |
60 |
2.73 |
308.366 |
5 |
0 |
0 |
|
3h |
Indolyl |
82 |
46 |
4.92 |
357.438 |
4 |
0 |
0 |
|
3i |
Dimethyl aminyl |
78 |
47 |
2.08 |
285.372 |
4 |
0 |
0 |
|
3j |
2-amino pyridinyl |
84 |
31 |
1.80 |
334.425 |
5 |
0 |
0 |
Table 2. Spectral analysis of 3a-j
|
Compds |
IR (Cm-1, KBr) |
1H NMR/ CDCl3 /DMSO-d6 ppm |
MS(m/z) |
|
3a |
1597(C=O), 1429(C=C), 1384(C-N), 739(C-S) |
(s,2H,CH2)3.40,(m,7H,ArH)6.53-.8.04 |
330 |
|
3b |
1596(C=O), 1429(C=C), 1388(C-N), 739(C-S) |
(s,2H,CH2)3.40,(m,7H,ArH)6.52-8.04 |
339 |
|
3c |
1639(C=O), 1478(C=C), 1384(C-N), 703(C-S) |
(s,2H,CH2)1.15,(m,7H,ArH)7.03-8.23 |
306 |
|
3d |
1594(C=O), 1446(C=C), 749(C-S) |
(s,2H,CH2)3.84,(m,7H,ArH)6.53-7.84 |
311 |
|
3e |
3449(N-H), 1630(C=O), 1431(C=C), 1384(C-N), 740(C-S) |
(s,2H,CH2)3.40,(m,7H,ArH)6.53-7.84 |
326 |
|
3f |
1597(C=O), 1429(C=C), 1384(C-N), 739(C-S) |
(s,2H,CH2)3.4,(m,7H,ArH) 6.53-7.84 |
307 |
|
3g |
1597(C=O), 1429(C=C), 1384(C-N), 739(C-S) |
(s,2H,CH2)3.48,(m,7H,ArH)6.53-7.84 |
309 |
|
h |
1596(C=O), 1429(C=C), 1310(C-N), 741(C-S) |
(s,2H,CH2)1.90,(m,7H,ArH)6.49-8.23 |
350 |
|
3i |
1596(C=O), 1430(C=C), 1308(C-N), 750(C-S) |
(s,2H,CH2)3.30,(m,7H,ArH)6.53-7.84 |
285 |
|
3j |
3443(N-H), 1596(C=O), 1427(C=C), 1384(C-N), 739(C-S) |
(s,2H,CH2)1.15,(m,7H,ArH)7.03-8.23 |
334 |
SCHEME 1. Synthesis of Azaphenothiazine derivatives.
Table 3: Antimicrobial activity of compounds 3a-j
|
Compounds |
Zone of inhibition( in mm) |
|||
|
Vibrio cholerae |
Bacillus spharicus |
Salmonella typhi |
Enterococcus feacalis |
|
|
3a |
7 |
8 |
10 |
8 |
|
3b |
14 |
6 |
11 |
5 |
|
3c |
7 |
11 |
6 |
5 |
|
3d |
10 |
4 |
10 |
8 |
|
3e |
15 |
7 |
11 |
5 |
|
3f |
7 |
8 |
6 |
9 |
|
3g |
8 |
10 |
12 |
6 |
|
3h |
7 |
11 |
14 |
7 |
|
3i |
9 |
7 |
7 |
6 |
|
3j |
7 |
12 |
5 |
7 |
|
Amoxicillin |
18 |
16 |
18 |
20 |
SEDATIVE ACTIVITY:
Sedative activity9 of compounds 3a-j was measured for locomotor activity,motor co-ordination test and Phenobarbitone hypnosis. Swiss albino mice of either sex weighing 25-30g were used for this study. Locomotor activity and motor co-ordination test were performed using Diazepam as standard drugs. Phenobarbitone was used as standard drug for Phenobarbitone hypnosis the standard and test compounds were administered i.p. (1mg/ml). Time of onset of action, duration of action and percentage decrease in activities were recorded and tabulated in Table 4.
Table 4: Sedative activity of compounds 3a-j
|
Compounds |
Phenobarbitone hypnosis |
Locomotor activity |
Motor co-ordination test |
|
|
Onset of sleep |
Duration of action |
%decrease in activity |
%decrease in activity |
|
|
3a |
5.42±0.32 |
36.12±0.32 |
.40.9±0.22 |
56. ±0.45 |
|
3b |
6.42±0.94 |
30.15±0.33 |
45.4±0.15 |
62.4±0.62 |
|
3c |
4.42±0.90 |
37.94±0.47 |
47.7±0.57 |
76.3±0.59 |
|
3d |
5.11±0.16 |
40.15±0.49 |
54.5±0.58 |
82.3±0.32 |
|
3e |
5.37±0.22 |
29.31±0.36 |
39.2±0.24 |
70.8±0.77 |
|
3f |
4.31±0.72 |
42.37±0.22 |
51.5±0.27 |
78.3±0.31 |
|
3g |
4.16±0.21 |
34.31±0.72 |
35.9±0.55 |
61.2±0.22 |
|
3h |
4.40±0.94 |
37.52±0.33 |
39.7±0.32 |
75.3±0.73 |
|
3i |
6.33±0.42 |
32.74±0.46 |
56.2±0.54 |
71.5±0.61 |
|
3j |
5.82±0.01 |
33.16±0.21 |
31.6±0.29 |
62.5±0.49 |
|
Phenobarbitone |
3.56±0.41 |
40.16±0.35 |
- |
- |
|
Diazepam |
- |
- |
58.90±0.64 |
74.16±0.11 |
CONCLUSION:
According to Lipinski rule of 5 no violation is seen in any of the compounds. Hence, all the titled compounds assumed to have good bioavailability.From the antimicrobial screening it was observed that the new azaphenothiazine derivatives show mild antimicrobial activity against all the organisms employed. From sedative studies it is clear that the compounds with amino substitution like dimethyl amine, diethyl amine and pyrolidine show significant sedative activity. It reveals that as the basicity of the compound increases the sedative activity of the compound also increases.
ACKNOWLEDGEMENT:
Authors are thankful to The Dean Dr. K. S. Lakshmi, SRM College of Pharmacy, for her constant encouragement and providing necessary facilities to carryout this work
REFERENCES:
1. David Williams A and Thomas Lemke L.Foye’s Principles of Medicinal Chemistry Lippincott Williams and Wilkins.New york.2005;5th ed:pp : 412-414..
2. Yale.andSowinskiF.Synthesisof10(dialkylaminoalkyl)pyridino[3,2b][1,4]benzothiazine(1-azaphenothiazine) and related compounds.J.Chem Soc.1958;15:77-81.
3. Craig PN et al .Synthesis of 10-aminoalkyl deravative of 2- substituted phenothiazine and aza phenothiazinesand its tranquillizing activity.J Org Chem.1959;24:944-948
4. Hansch C,Sammes PG andTaylor JB and Dorayton CJ. Comprehensive Medicinal Chemistry,vol-6,Pergamon press,2005;pp229
5. Gennaro AR. Synthesis and antimicrobial activityof Pyrido[3,2-b][1,4] benzothiazine (1-azaphenothiazine).J Am Chem Soc.1959;24:1156-1160.
6. GrossA et al. Synthesis and Pharmacological Properties of 2-Chloro-4-azaphenothiazine:Arzneimttel forchung.1968;18(4):435-42
7. Wilson and Giswold’s Text book of Pharmaceutical Chemistry,Lippincott Williams and Wilkis Publication,2004;pp:944-945.
8. Bhatt AK et al. Synthesis of benzimidazoyl phenothizine and their antibacterial and antifungal activities.Ind J Het Chem. 2004;13:281-282.
9. Turner RA. Screening Methods in Pharmacology,Academic press,New york1965;pp:142-145.
Received on 24.04.2009 Modified on 23.06.2009
Accepted on 17.07.2009 © AJRC All right reserved
Asian J. Research Chem. 2(4):Oct.-Dec. 2009 page 411-413